Turkey: New Legislations on Pricing and Manufacturing Plants of Human Medicinal Products

Last Updated: 6 December 2017
Article by Gönenç Gürkaynak Esq, Ceren Yıldız and Ecem Elver

Most Read Contributor in Turkey, October 2018

The Ministry of Health had two major items on its legislative agenda during the last quarter of 2017, which may impact the manufacturers and importers of human medicinal products, as these items pertain to the manufacturing as well as the pricing of medicines.

On September 29, 2017, the Ministry of Health ("Ministry") published the new Communiqué on the Pricing of Human Medicinal Products ("Pricing Communiqué") in the Official Gazette. Upon the publication of the Pricing Communiqué, the predecessor Communiqué on the Pricing of Human Medicinal Products ("Abolished Communiqué") has been abrogated.

After the new Pricing Communiqué went into effect, the Ministry set its sights on manufacturing plants of human medicinal products and rolled up its sleeves to introduce a new regulation regarding such plants, known as the Regulation on Manufacturing Plants of Human Medicinal Products ("Manufacturing Regulation"). Aiming to regulate the manufacturing and importing of human medicinal products and to bring them in line with internationally acknowledged/implemented standards, the Ministry published the Manufacturing Regulation in the Official Gazette of October 21, 2017. Upon the publication of the Manufacturing Regulation, the predecessor Regulation on Human Medicinal Products Manufactories has been abrogated.

- First Look at the Pricing Communiqué

The Pricing Communiqué adopts a simpler and more user-friendly language regarding the technicalities of drug pricing principles, which are aimed at regulating the Turkish drug pricing system as well as the encouragement of domestic drug manufacturing. The most striking amendment introduced with the Pricing Communiqué is that prices in this market will be amended once a year, rather than the "twice a year" arrangement that was in force under the Abolished Communiqué. 

Pricing principles are regulated under Article 7 of the Pricing Communiqué. In this sense, compared to the Abolished Communiqué, it is clearly seen that the Ministry has developed and set forth more detailed pricing principles:

- Transition Period for New Pricing Principles

The Ministry has announced its transition schedule under Provisional Article 1 of the Pricing Communiqué. In this respect, the sales prices to the wholesalers for the products falling within the scope of the following provision, which was abolished by the Decision, will be updated during the real source price amendment period of 2017, in line with their source prices: "The changes in the selling price to the wholesalers approved in Turkey due to the change in reference price or reference country shall not be reflected in the price, unless it exceeds 3%. Only reference and reference country information shall be updated."

Changes that lead to an increase in price will be made upon the request of the license-holders, while changes which lead to a decrease in price will be made by the Institution ex officio. These updated prices will be effective as of the effective date of the final interim list, which will be issued at the end of the actual source price amendment period.

Finally, amendments introduced with the Pricing Communiqué regarding the real source price amendment period will not be applied to the real source price amendment period of 2017, except for Paragraphs 1, 4, 5 and 7 of Article 10. Provisions under the Abolished Communiqué will be taken into account and applied for the real source price amendment period of 2017.

- Manufacturing Plants of Human Medicinal Products in a Nutshell

With the Manufacturing Regulation, the Ministry has broadened the responsibilities of license/permit holders. In this respect, the Ministry has added certain provisions to the responsibility list, which seem to impose a strict monitoring liability to license holders.

For instance, license holders will be responsible for assigning a manager within 30 days after the resignation of the previous manager and notifying the Ministry accordingly. Furthermore, license holders will have to possess and retain the documentation proving that the manufacturers, importers or distributors of active agents with whom they work are duly registered with the relevant authorities in their countries. License holders, in this respect, will have to verify and confirm the safety and quality of the active agents and the inactive ingredients that they use, and ensure that they maintain necessary and adequate control over human medicinal products as well as active agents during all stages of manufacturing.

Article 10 of the Manufacturing Regulation lays out detailed arrangements and instructions with respect to the auditing of human medicinal product manufacturing sites.

Article 13 of the Manufacturing Regulation sets forth important principles regarding the importation of human medicinal products and imposes certain responsibilities on importers and license holders.

The Principles regarding active agents and inactive ingredients are regulated under Article 14 of the Manufacturing Regulation. According to Article 14(2), permit/license holders must confirm that the manufacturers and distributors of their active agents are in compliance with the principles of Good Manufacturing Practices and Good Delivery Practices, by way of auditing the manufacturing and distribution sites of such manufacturers and distributors.

On a side note, as per Article 32 of the Manufacturing Regulation, Article 14(2) will come into effect one year after the date of publication of the Regulation (i.e., on October 21, 2018).

Article 27 of the Manufacturing Regulation provides a more detailed and comprehensive regulation regarding sanctions to be imposed on license/permit holders as well as managers. While the Ministry retains its suspension and withdrawal authority, certain changes made in the Article shed light on the process in the aftermath of a suspension/withdrawal.

Importers who wish to conduct only batch-release operations are obliged to apply to the Ministry and obtain a permit within one year as of the publication date of the Manufacturing Regulation.


This article was first published in Legal Insights Quarterly by ELIG, Attorneys-at-Law in December 2017. A link to the full Legal Insight Quarterly may be found here.


The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions